Galapagos NV
GLPG
#4563
Rank
$2.11 B
Marketcap
$31.59
Share price
-0.57%
Change (1 day)
17.04%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : $8.8 Million USD

According to Galapagos NV's latest financial reports the company's total debt is $8.8 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$12.19 M14.99%
2023-12-31$10.6 M-54.85%
2022-12-31$23.49 M-22.77%
2021-12-31$30.41 M-15.99%
2020-12-31$36.2 M27.32%
2019-12-31$28.43 M
2018-12-31N/A-100%
2017-12-31$0.01 M-83.7%
2016-12-31$0.06 M-47.3%
2015-12-31$0.12 M-38.09%
2014-12-31$0.2 M-62.58%
2013-12-31$0.54 M1.31%
2012-12-31$0.53 M-52.91%
2011-12-31$1.13 M-31.3%
2010-12-31$1.65 M-22.11%
2009-12-31$2.12 M-9.8%
2008-12-31$2.35 M-63.04%
2007-12-31$6.37 M-37.77%
2006-12-31$10.24 M8.59%
2005-12-31$9.43 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
$32.63 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
$45.79 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$25.53 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
$68.74 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
$69.21 M 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$12.94 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$23.86 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$41.37 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA